SOCIUM
Latest round
- Series B
Last raised
- Dec 2020
Total raised
- $4.7M
Investors
- 1
About SOCIUM
SOCIUM Inc.Founded in 2017, SOCIUM Inc. operates primarily from Tokyo, Japan, specializing in drug discovery.SOCIUM Inc. specializes in drug discovery and related analytical services, concentrating on innovative solutions for biotechnology and pharmaceutical sectors. Their primary offerings include phosphorylation analysis services that facilitate understanding of molecular mechanisms in drug candidates. They also provide consulting services to help clients navigate drug development complexities. Collaborating with institutions like Nanjing Medical University and Huaxi Hospital of Sichuan University, they enhance research in treating amyotrophic lateral sclerosis (ALS).SOCIUM Inc. generates revenue through service contracts and partnerships with both public and private sector organizations. The company operates under a contract research model, where clients hire SOCIUM for specific projects involving detailed studies of drug candidates and their molecular interactions. This model typically involves project-based fees negotiated at the outset, enabling tailored solutions for clients' unique research needs.In July 2021, SOCIUM Inc. The company is focused on developing new products and services while targeting increased market penetration in specific regions. Future plans include expanding into new markets, although specific regions have not been disclosed.
Who invested in SOCIUM
1 investor across 2 rounds
See all investors in SOCIUM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SOCIUM
Who invested in SOCIUM?
SOCIUM has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SOCIUM raised?
SOCIUM has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SOCIUM last raise money?
SOCIUM's most recent round on record is a Series B, in Dec 2020.
What does SOCIUM do?
SOCIUM is a pharmaceuticals company.
Where is SOCIUM headquartered?
SOCIUM is headquartered in Tokyo, Japan.
Which VCs invest in companies like SOCIUM?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at SOCIUM's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like SOCIUM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.